Jeffrey R. Stewart is president, for U.S. Commercial Operations. Prior to AbbVie’s separation from Abbott in January 2013, he served as vice president, proprietary pharmaceuticals, United States.
Mr. Stewart joined Abbott in 1992 as part of TAP, Abbott’s former U.S. joint venture with Takeda Chemical Industries. Since his time with TAP, Mr. Stewart has held various leadership positions in Abbott’s U.S. and international pharmaceutical businesses, including divisional vice president, immunology; general manager, virology; general manager, United Kingdom; and divisional vice president, primary care.
He earned a bachelor’s degree in history from Princeton University.